SEARCH RESULT

Total Matching Records found : 58

Refund and a deeper malaise -GS Mudur

-The Telegraph New Delhi: The father of an eight-year-old boy who died in a private hospital in Gurgaon last year from dengue complications said on Thursday the hospital had refunded the full billed amount of about Rs 15 lakh after appeals by an MP and the health ministry. Public health activists said the refund had been made on condition that Gopendra Parmar withdraw the police complaint of overcharging he had filed against...

More »

Transfer of NPPA head who capped stent, implant prices sparks protests

-The Times of India The transfer of the chairman of the National Pharmceutical Pricing Authority, Bhupendra Singh, who had capped the price of stents and knee implants and exposed the huge margins being charged by corporate hospitals has evoked howls of protest from public health activists. RSS-affiliate Swadeshi Jagran Manch too has taken exception to the move, tweeting sarcastically about the “reward” given to a bureaucrat for doing a good job. The All...

More »

Cry to widen stent price cap -GS Mudur

-The Telegraph New Delhi: Health activists campaigning for affordable treatment on Wednesday urged the Narendra Modi government to resist "pressure" from foreign medical device makers and expand price caps to new classes of medical devices. The All India Drug Action Network (AIDAN), a consortium of non-government activists' groups, said it was concerned that a body of foreign medical device manufacturers had petitioned the US government seeking suspension or withdrawal of certain trade...

More »

Flawed drug price rules fleeced patients, helped hospitals -GS Mudur

-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...

More »

Can doctors judge best quality in medicines? -Jyotsna Singh

-The Hindu Doctors’ objections to prescribing medicines by generic names fly in the face of a recent report on substandard drugs In a surprise move on April 17, Prime Minister Narendra Modi announced that his government will soon make it mandatory for doctors to prescribe medicines by generic names. The decision was to ensure drug prices remain affordable and patients get a wider bouquet of options instead of being forced to...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close